On This Page

Controlled Substances - Resources and References

  1. Government of Canada- Controlled Drugs and Substances Act and regulations
    http://laws-lois.justice.gc.ca/eng/acts/C-38.8/

  2. Health Canada- Office of Controlled Substances
    http://www.hc-sc.gc.ca/contact/dhp-mps/hecs-dgsesc/ocs-bsc-eng.php

  3. Health Canada- Information for Health Care Professionals: Cannabis and the cannabinoids
    http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/marihuana/med/infoprof-eng.pdf

  4. Government of Ontario- Narcotics Safety and Awareness Act, 2010
    https://www.ontario.ca/laws/statute/10n22

  5. Government of Ontario- Narcotic’s Strategy and Narcotics Monitoring System
    http://www.health.gov.on.ca/en/pro/programs/drugs/ons/

  6. Government of Ontario- Safeguarding our Communities Act (Patch for Patch Return Policy), 2015
    https://www.ontario.ca/laws/statute/15s33

  7. Ontario College of Pharmacists & College of Physicians and Surgeons of Ontario. (2016). Patch-For-Patch Fentanyl Return Program fact sheet
    http://www.ocpinfo.com/regulations-standards/policies-guidelines/Patch_For_Patch_Fentanyl_Return_Fact_Sheet/ and

  8. Ontario College of Pharmacists & College of Physicians and Surgeons of Ontario. (2016). Prescribing Drugs: Fentanyl Fact Sheets.
    http://www.cpso.on.ca/cpso/media/documents/policies/policy-items/prescribing-drugs-fentanyl-factsheet.pdf

  9. College of Physicians and Surgeons of Ontario. (2016). Marijuana for medical purposes.
    http://www.cpso.on.ca/Policies-Publications/Policy/Marijuana-for-Medical-Purposes

  10. Canadian Guidelines for Use of Opioids in Chronic Non Cancer Pain
    http://nationalpaincentre.mcmaster.ca/guidelines.html

  11. CAMH- Buprenorphine/Naloxone for Opioid Dependence
    https://www.porticonetwork.ca/documents/489955/0/Buprenorphine+and+Naloxone+-+Clinical+Practice+Guidelines+2012+PDF/fd1eee5d-fd7f-4b58-961f-b45350a8b554?intcid=search-results

  12. Portico-Addiction and Mental Health Clinical Tools (Powered by the Centre for Addiction and Mental Health)
    https://www.porticonetwork.ca/

  13. Institute for Safe Medication Practices Canada Safety Bulletin. (2017).  Helping Patients and Practitioners to Understand Opioid Potencies and Overdose Risk
    https://www.ismp-canada.org/download/safetyBulletins/2017/ISMPCSB2017-08-UnderstandOpioids.pdf?utm_source=safetybulletin&utm_medium=email&utm_campaign=sbv17i08#page=1

  14. Center for Disease Control Guideline for Prescribing Opioids for Chronic Pain – United States,
    http://dx.doi.org/10.15585/mmwr.rr6501e1

  15. Project ECHO (Extension of Community Healthcare Outcomes)
    https://www.echoontario.ca/Home.aspx
    https://www.echoontario.ca/Echo-Clinic/Chronic-Pain.aspx
    https://www.echoontario.ca/Echo-Clinic/Mental-Health-and-Addictions.aspx
  16. The National Academies of Sciences and Engineering- The Health Effects of Cannabis and Cannabinoids
    https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state

  17. The National Academies of Sciences, Engineering and Medicine - Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use
    https://www.nap.edu/catalog/24781/pain-management-and-the-opioid-epidemic-balancing-societal-and-individual
  18. Canadian Council of RN Regulators
    https://www.canada.ca/en/health-canada/services/substance-abuse/opioid-conference/joint-statement-action-address-opioid-crisis.html

  19. Canadian Centre on Substance Abuse
    http://www.ccsa.ca/Pages/default.aspx

  20. Canadian Agency for Drugs and Technologies in Health (CADTH) report: Buprenorphine/Naloxone Versus Methadone for the Treatment of Opioid Dependence: A Review of Comparative Clinical and Cost-Effectiveness and Guidelines
    https://www.cadth.ca/buprenorphinenaloxone-versus-methadone-treatment-opioid-dependence-review-comparative-clinical
Page last reviewed October 30, 2017